Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

622
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
622

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A mouse model to study persistent fatigue.

Research square·2026
Same author

Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitors.

Bioorganic & medicinal chemistry letters·2025
Same author

A high-throughput human tissue model for respiratory viruses: Automating the use of human airway epithelial tissues for faster drug discovery.

SLAS discovery : advancing life sciences R & D·2025
Same author

High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay.

Antiviral research·2025
Same author

4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses.

Journal of medicinal chemistry·2024
Same author

Pregabalin produces analgesia in males but not females in an animal model of chronic widespread muscle pain.

Pain reports·2024
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K

Mycobacterium tuberculosis High-Throughput Screening.

E Lucile White1, Nichole A Tower2, Lynn Rasmussen2

  • 1High Throughput Screening Center, Southern Research Institute, Birmingham, AL, USA. lwhite@southernresearch.org.

Methods in Molecular Biology (Clifton, N.J.)
|June 19, 2016
PubMed
Summary
This summary is machine-generated.

High-throughput screening aids antibiotic discovery. This method efficiently screens large compound libraries against virulent Mycobacterium tuberculosis, a challenging pathogen.

Keywords:
AntibacterialAntibioticsAntimicrobialAntitubercularH37RvHTSHigh-throughput screeningMtbMycobacterium tuberculosisTBTuberculosis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Area of Science:

  • Microbiology
  • Drug Discovery
  • Infectious Diseases

Background:

  • High-throughput screening (HTS) is crucial for identifying novel antibiotic compounds.
  • Mycobacterium tuberculosis presents unique challenges for HTS due to slow growth and Biosafety Level-3 requirements.
  • Developing new antibiotics is essential to combat rising antimicrobial resistance.

Purpose of the Study:

  • To describe a robust method for HTS against virulent Mycobacterium tuberculosis.
  • To demonstrate the applicability of HTS principles to challenging bacterial pathogens.
  • To facilitate the discovery of new anti-tuberculosis agents.

Main Methods:

  • Adaptation of HTS protocols for slow-growing, BSL-3 bacteria.
  • Screening of large compound libraries using virulent M. tuberculosis.
  • Optimization of assay conditions for bacterial HTS.

Main Results:

  • Successful implementation of an HTS method for M. tuberculosis.
  • Identification of potential hit compounds for further development.
  • Demonstration of transferable HTS principles for other difficult-to-culture bacteria.

Conclusions:

  • The developed HTS method is effective for identifying anti-tuberculosis drug candidates.
  • This approach can be adapted for HTS against other hazardous or slow-growing bacteria.
  • Medicinal chemistry combined with HTS offers a viable path to new antibiotic discovery.